Top Suppliers:I want be here

104632-25-9

104632-25-9 structure
104632-25-9 structure
  • Name: Pramipexole dihydrochloride
  • Chemical Name: pramipexole hydrochloride anhydrous
  • CAS Number: 104632-25-9
  • Molecular Formula: C10H19Cl2N3S
  • Molecular Weight: 284.249
  • Catalog: API Nervous system medication Parkinson's syndrome
  • Create Date: 2018-07-23 17:28:06
  • Modify Date: 2026-07-23 08:06:29
  • Pramipexole 2Hcl is a partial/full D2S, D2L, D3, D4 receptor agonist with a Ki of 3.9, 2.2, 0.5 and 5.1 nM for D2S, D2L, D3, D4 receptor, respectively. IC50 Value: 3.9 nM(D2S); 2.2 nM(D2L); 0.5 nM(D3); 5.1 nM(D4)Target: Dopamine ReceptorPramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. Pramipexole has been found to have neuroprotective effects independent of its dopamine receptor agonism. It reduces mitochondrial reactive oxygen species (ROS) production and inhibits the activation of apoptotic pathways. Pramipexole displays activity in the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS).

Name pramipexole hydrochloride anhydrous
Synonyms Pramipexole dihydrochloride (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride
Pramipexole dihydrochloride, Dopamine D2-like rector agonist. D3-preferring
PRAMPEXOL HCL
(6S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine Dihydrochloride
Pramexole 2HCl
Pramipexole Impurity 83 DiHCl
Crufomate Impurity 4
Pramipexole dihydrochloride salt
Pramipexole (dihydrochloride)
(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride
PRAMIPEXOL HCL
2,6-BenzothiazolediaMine, 4,5,6,7-tetrahydro-N6-propyl-, hydrochloride (1:2), (6S)
(6S)-N-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrochloride
Pramipexole dihydrochloride [usan]
Benzoicacid,3-bromo-6-ethyl
Pramipexole Impurity 4 //BP
(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine dihydrochloride
Praxole
(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride
MFCD00876894
(S)-Pramipexole Dihydrochloride
PraMipexole dihydrochlor
2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, dihydrochloride, (S)
2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, dihydrochloride, (6S)
PRAMIPEXOLE DIHYDROCHLORIDE
PramipexoleDihcl
2,6-BenzothiazolediaMine,4,5,6,7-tetrahydro-N6-propyl-, hydrochl
(S)-Pramipexole-d7 Dihydrochoride
2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N-propyl-, (6S)-, hydrochloride (1:2)
PRAMIPEXOLE HYDROCHLORIDE
(S)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol2HCltetrahydrobenzothiazol
(s)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine, Dihydrochloride
Pramipexole dihydrochlorideQ: What is Pramipexole dihydrochloride Q: What is the CAS Number of Pramipexole dihydrochloride Q: What is the storage condition of Pramipexole dihydrochloride
Pramipexole hydrochloride
(s)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride
(S)-Pramipexole (hydrochloride)
PRAMIPEXOLE HCL
Description Pramipexole 2Hcl is a partial/full D2S, D2L, D3, D4 receptor agonist with a Ki of 3.9, 2.2, 0.5 and 5.1 nM for D2S, D2L, D3, D4 receptor, respectively. IC50 Value: 3.9 nM(D2S); 2.2 nM(D2L); 0.5 nM(D3); 5.1 nM(D4)Target: Dopamine ReceptorPramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. Pramipexole has been found to have neuroprotective effects independent of its dopamine receptor agonism. It reduces mitochondrial reactive oxygen species (ROS) production and inhibits the activation of apoptotic pathways. Pramipexole displays activity in the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS).
Related Catalog
References

[1]. Mierau J, Schneider FJ, Ensinger HA et al. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. Eur J Pharmacol. 1995 Jun 23;290(1):29-36.

[2]. El-Mallakh RS, Penagaluri P, Kantamneni A et al. Long-term use of pramipexole in bipolar depression: a naturalistic retrospective chart review. Psychiatr Q. 2010 Sep;81(3):207-13.

[3]. Perez-Lloret S, Rey MV, Ratti L, Rascol O. Pramipexole for the treatment of early Parkinson's disease. Expert Rev Neurother. 2011 Jul;11(7):925-35.

[4]. Hametner EM, Seppi K, Poewe W. Pramipexole extended release in Parkinson's disease. Expert Rev Neurother. 2011 Sep;11(9):1229-34.

[5]. Hametner EM, Seppi K, Poewe W. Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease. Clin Interv Aging. 2012;7:83-8.

Boiling Point 378ºC at 760 mmHg
Melting Point 288-290ºC
Molecular Formula C10H19Cl2N3S
Molecular Weight 284.249
Flash Point 182.4ºC
Exact Mass 283.067688
PSA 79.18000
LogP 4.15830
Vapour Pressure 6.49E-06mmHg at 25°C
Storage condition Desiccate at RT
Hazard Codes Xi
RIDADR NONH for all modes of transport
HS Code 2934999090

~84%

104632-25-9 structure

104632-25-9

Literature: INSTYTUT FARMACEUTYCZNY Patent: WO2007/75095 A1, 2007 ; Location in patent: Page/Page column 7 ;

~72%

104632-25-9 structure

104632-25-9

Literature: Ravinder; Rajeswar Reddy; Panasa Reddy; Bandichhor, Rakeshwar Tetrahedron Letters, 2013 , vol. 54, # 36 p. 4908 - 4913

~98%

104632-25-9 structure

104632-25-9

Literature: Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1878731 A1, 2008 ; Location in patent: Page/Page column 11 ;

~85%

104632-25-9 structure

104632-25-9

Literature: Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1878731 A1, 2008 ; Location in patent: Page/Page column 11 ;

~%

104632-25-9 structure

104632-25-9

Literature: WO2011/21214 A2, ;

~%

104632-25-9 structure

104632-25-9

Literature: WO2011/21214 A2, ;

~%

104632-25-9 structure

104632-25-9

Literature: WO2011/21214 A2, ;

~%

104632-25-9 structure

104632-25-9

Literature: WO2011/21214 A2, ;

~%

104632-25-9 structure

104632-25-9

Literature: WO2011/21214 A2, ;
HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.